Cafepharma Today

May 22 2025 - Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
Sanofi inks $470M Vigil buyout, brushing off rivals' failures to join Novartis in Alzheimer's race
FDA advisors unanimously snub Pfizer's Talzenna in broader prostate cancer population
Prices for new US drugs doubled in 4 years as focus on rare disease grows
FDA expands warnings of heart risks on COVID shots
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sanofi-Aventis (NYSE: SNY) Upgraded by Zacks Investment Research to “Outperform”
American Banking Market News
Saturday, December 11, 2010 - 1:01pm
tags:
Sanofi, investors
Avanir Pharmaceuticals Chart Point to Possible Trend Reversal
Wall Street Newscast
Saturday, December 11, 2010 - 12:59pm
tags:
Avanir, investors
Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
PR-USA
Saturday, December 11, 2010 - 12:57pm
tags:
Afatinib, breast cancer, Boehringer Ingelheim
Pfizer tops the list as big pharma turns to acquisitions as its preferred growth track
The Day, CT
Saturday, December 11, 2010 - 12:56pm
tags:
Pfizer
Strides Arcolab Limited enters agreement to acquire 70 per cent of the Bangalore based biotechnology firm Inbiopro Solutions
investinindia, India
Saturday, December 11, 2010 - 12:54pm
tags:
Strides Arcolab, Inbiopro
Biotech Sector Weekly Rewind
The Street
Saturday, December 11, 2010 - 12:53pm
tags:
biotech
Generic-Drug Makers Get Hearing at U.S. High Court
Bloomberg
Saturday, December 11, 2010 - 12:51pm
tags:
generics
New CEO will have full plate at Pfizer
The Day, CT
Saturday, December 11, 2010 - 12:50pm
tags:
Pfizer
Frudakis vs. Merck Pharmaceutical Complaint Against Merck for Failing to Pay Drug Sales Reps Overtime
JD Supra
Saturday, December 11, 2010 - 12:49pm
tags:
Merck, overtime lawsuits
CorMedix (CRMD): Undervalued and Under Investor’s Radar
istockanalyst
Saturday, December 11, 2010 - 12:45pm
tags:
CorMedix, cardiorenal, Neutrolin, Deferiprone, Contrast Induced-Nephropathy, catheters
Teva Pharma (TEVA) Files Citizens Petition with U.S. FDA for COPAXONE
Street Insider
Saturday, December 11, 2010 - 12:14pm
tags:
Teva Pharmaceuticals, Copaxone
Putin Strengthens Russian Drug Industry
Seeking Alpha
Saturday, December 11, 2010 - 12:11pm
tags:
Russia
Abbott board declares 44 cent quarterly dividend
Yahoo/AP
Saturday, December 11, 2010 - 12:09pm
tags:
Abbott Laboratories, investors
Pfizer calls WikiLeaks cable ‘preposterous’
Financial Times
Saturday, December 11, 2010 - 12:08pm
tags:
Pfizer
Merck Closes on $2 Billion Notes Sale
The Street
Saturday, December 11, 2010 - 12:07pm
tags:
Merck
Drug combo helps women with early breast cancer
Yahoo/AP
Saturday, December 11, 2010 - 12:00pm
tags:
Tykerb, Herceptin, HER2 Inhibitor, breast cancer, Genentech, GSK
Something Is Better Than Nothing, I Guess (Novartis, Zometa)
Motley Fool
Saturday, December 11, 2010 - 11:50am
tags:
Novartis, Zometa, breast cancer
ImmunoGen, Inc. Announces Clinical Data for T-DM1 Used in Combination with Pertuzumab for First-Line Treatment of HER2+ Metastatic Breast Cancer
Yahoo/BusinessWire
Saturday, December 11, 2010 - 11:48am
tags:
Immunogen, T-DM1, Pertuzumab, breast cancer, HER2 Inhibitor, trastuzumab
Amgen Presents New XGEVA (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Yahoo/PR NewsWire
Saturday, December 11, 2010 - 11:41am
tags:
Amgen, denosumab, Xgeva, breast cancer
Cypress Surges After Ramius Boosts Buyout Offer 29 Percent to $212 Million
Bloomberg
Saturday, December 11, 2010 - 11:40am
tags:
Cypress Bioscience, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.